ストックスクリーナーアプリを入手
137.47
0.67%
0.92
プレマーケット:
137.46
-0.010
-0.01%
前日終値:
$136.55
開ける：
$136.74
24時間の取引高:
295.22K
Relative Volume:
0.61
時価総額：
$3.97B
収益：
$267.23M
当期純損益:
$-83.50M
株価収益率:
-44.20
EPS:
-3.11
ネットキャッシュフロー:
$-59.99M
1週間 パフォーマンス:
+5.70%
1か月 パフォーマンス:
-13.97%
6か月 パフォーマンス:
+61.31%
1年 パフォーマンス:
+42.35%
1日の値動き範囲:
$133.35
$137.97
1週間の範囲:
$124.26
$139.00
52週間の値動き範囲:
$55.17
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
WGS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
137.47 | 3.95B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-20 | 開始されました | Canaccord Genuity | Buy |
| 2025-07-09 | 開始されました | Piper Sandler | Overweight |
| 2025-05-15 | 開始されました | Guggenheim | Buy |
| 2025-05-09 | アップグレード | Jefferies | Hold → Buy |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-07-10 | 開始されました | Craig Hallum | Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
すべてを表示
Genedx Holdings Corp (WGS) 最新ニュース
Why GeneDx Holdings Corp. stock could rally in 2025Swing Trade & Smart Money Movement Tracker - ulpravda.ru
How GeneDx Holdings Corp. stock trades during market volatilityMarket Activity Summary & Reliable Price Breakout Signals - ulpravda.ru
Is GeneDx Holdings Corp. Equity Warrant stock positioned for digital transformation2025 Trading Volume Trends & Advanced Swing Trade Entry Plans - ulpravda.ru
GeneDx partners with Komodo Health to create comprehensive rare disease dataset - Investing.com Canada
New rare disease database links DNA and real-world care for 330M patients - Stock Titan
How GeneDx Holdings Corp. stock reacts to job market dataDividend Yield Trends & Free Unlock Rapid Growth Potential - ulpravda.ru
GeneDx Announces GenomeDx Prenatal, Expanding Genomic Diagnosis into Prenatal Care - MarketScreener
GeneDx to launch whole genome sequencing test for fetal anomalies By Investing.com - Investing.com Canada
New prenatal genome test offers faster answers after troubling ultrasounds - Stock Titan
A Look At GeneDx Holdings (WGS) Valuation After New CMO Appointment And Record Rare Disease Genomics Year - Yahoo Finance
GeneDx appoints Dr. Linda Genen as CMO - MSN
GeneDx Holdings Corp.Class A Common Stock (NQ: WGS - FinancialContent
GeneDx appoints Linda Genen as chief medical officer By Investing.com - Investing.com Australia
GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care (2026-01-06) - Seeking Alpha
Should GeneDx’s GUARDIAN Newborn Genomics Accolade Reshape the Investment Narrative for WGS Investors? - simplywall.st
GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025 - Business Wire
(WGS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript - MSN
What Do Analysts Think About GeneDx Holdings Corp. (WGS)? - Insider Monkey
Simplify Asset Management Inc. Sells 41,071 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference - MarketScreener
Genomics firm GeneDx joins major J.P. Morgan healthcare event - Stock Titan
Ajooni Biotech Limited Uptrend in Early Stages Indicators Say YesVolatility Index Analysis & You’ve Never Seen Stock Picks Like These - earlytimes.in
GeneDx Holdings Corp. $WGS Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Assenagon Asset Management S.A. Has $1.52 Million Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat
Behavioral Patterns of WGS and Institutional Flows - Stock Traders Daily
What analysts say about GeneDx Holdings Corp Equity Warrant stockReal Estate Investment Trusts & Rapid Portfolio Appreciation - earlytimes.in
WGS FinancialsIncome Statement - Quiver Quantitative
GeneDx Holdings (WGS) Sees Analyst Rating Update: Price Target R - GuruFocus
Canaccord Genuity Group Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - MarketBeat
Aug EndMonth: Is GeneDx Holdings Corp. Equity Warrant stock positioned well for digital economy2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
Is JAMA’s GUARDIAN Nod Quietly Reframing GeneDx (WGS) as a Core Newborn Genomics Platform? - simplywall.st
Is GeneDx Holdings Corp. Equity Warrant stock a safe buy before earnings2025 Winners & Losers & Low Drawdown Investment Strategies - Улправда
Investment Report: How GeneDx Holdings Corp. Equity Warrant stock reacts to job market data2025 Top Gainers & Weekly High Conviction Trade Ideas - Улправда
GeneDx (WGS) Valuation Check as JAMA Highlights GUARDIAN Newborn Genomic Screening Study - simplywall.st
How GeneDx Holdings Corp. Equity Warrant stock reacts to job market data2025 Year in Review & Real-Time Buy Signal Notifications - Улправда
How sustainable is GeneDx Holdings Corp. stock dividend payoutJuly 2025 Earnings & Low Drawdown Trading Techniques - Улправда
Can GeneDx Holdings Corp. stock beat market expectations this quarter2025 Top Decliners & Low Risk Entry Point Guides - Улправда
Risk Report: Is GeneDx Holdings Corp. Equity Warrant stock attractive for income investors2025 Geopolitical Influence & Accurate Intraday Trading Signals - Улправда
Why analysts upgrade GeneDx Holdings Corp. stockJuly 2025 Analyst Calls & Free High Return Stock Watch Alerts - Улправда
Is GeneDx Holdings Corp. Equity Warrant stock positioned well for digital economyJuly 2025 Setups & Growth Oriented Trade Recommendations - Улправда
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 10,857 Shares - MarketBeat
Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells 3,855 Shares of Stock - MarketBeat
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView — Track All Markets
CFO Feeley Acquires 3,342 Of GeneDx Holdings Corp [WGS] - TradingView — Track All Markets
GeneDx Holdings Corp. (WGS) CFO reports RSU vesting and sell-to-cover trades - Stock Titan
GeneDx (WGS) CEO discloses RSU vesting, tax-related stock sales - Stock Titan
Can GeneDx Holdings Corp. Equity Warrant stock surprise with earnings upsideJuly 2025 Opening Moves & AI Forecast for Swing Trade Picks - Улправда
GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next - ts2.tech
GeneDx (NASDAQ:WGS) Stock Price Down 6.4%What's Next? - MarketBeat
WGS: Wells Fargo Raises Price Target to $155, Maintains Equal-We - GuruFocus
Genedx Holdings Corp (WGS) 財務データ
収益
当期純利益
現金流量
EPS
0.37%
2.87%
大文字化:
|
ボリューム (24 時間):